Amir Reichman
Chief Executive Officer at SCINAI IMMUNOTHERAPEUTICS LTD.
Net worth: - $ as of 29/04/2024
Profile
Amir Reichman is the founder of NeuroDerm Ltd.
which was founded in 2003.
He was the Chief Engineer & Senior Scientist from 2003 to 2009.
Currently, he is the Chief Executive Officer & Director at Scinai Immunotherapeutics Ltd.
since 2021.
Previously, he worked at GlaxoSmithKline Pharmaceuticals SA (Belgium) as the Head-Global Vaccines Engineering Core Technology from 2015 to 2021 and at Novartis Vaccines & Diagnostics, Inc. (North Carolina) as the Head-Global Vaccines Value Chain Management from 2011 to 2015.
Mr. Reichman completed his undergraduate degree from Ben-Gurion University of the Negev and his MBA from The Wharton School of the University of Pennsylvania.
Known holdings in public companies
| Company | Date | Number of shares | Valuation | Valuation date |
|---|---|---|---|---|
| 14/03/2023 | 0 ( -.--% ) | - $ | 29/04/2024 |
Amir Reichman active positions
| Companies | Position | Start |
|---|---|---|
| SCINAI IMMUNOTHERAPEUTICS LTD. | Chief Executive Officer | 01/03/2021 |
Former positions of Amir Reichman
| Companies | Position | End |
|---|---|---|
GlaxoSmithKline Pharmaceuticals SA (Belgium)
 GlaxoSmithKline Pharmaceuticals SA (Belgium) Pharmaceuticals: MajorHealth Technology GlaxoSmithKline Pharmaceuticals SA develops and manufactures pharmaceuticals and vaccines. The company is headquartered in Wavre, Belgium. | Corporate Officer/Principal | 28/02/2021 |
| Novartis Vaccines & Diagnostics, Inc. (North Carolina) | Corporate Officer/Principal | 31/12/2014 |
| NEURODERM LTD | Founder | 31/12/2008 |
Training of Amir Reichman
| Ben-Gurion University of the Negev | Undergraduate Degree |
| The Wharton School of the University of Pennsylvania | Masters Business Admin |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Listed companies | 1 |
|---|---|
| SCINAI IMMUNOTHERAPEUTICS LTD. | Health Technology |
| Private companies | 3 |
|---|---|
NeuroDerm Ltd.
 NeuroDerm Ltd. BiotechnologyHealth Technology NeuroDerm Ltd. operates as a clinical-stage pharmaceutical company. It engages in the development of next-generation treatments for central nervous system disorders. The company was founded by Eliahu Heldman on March 18, 2003 and is headquartered in Rehovot, Israel. | Health Technology |
GlaxoSmithKline Pharmaceuticals SA (Belgium)
GlaxoSmithKline Pharmaceuticals SA (Belgium) Pharmaceuticals: MajorHealth Technology GlaxoSmithKline Pharmaceuticals SA develops and manufactures pharmaceuticals and vaccines. The company is headquartered in Wavre, Belgium. | Health Technology |
| Novartis Vaccines & Diagnostics, Inc. (North Carolina) |
- Stock Market
- Insiders
- Amir Reichman
